In 2015, multinational pharmaceutical companies have shown competition in the asthma and COPD treatments
Since the beginning of the New Year, multinational pharmaceutical companies have shown high interests in asthma and COPD (Chronic Obstructive Pulmonary Disease) treatments.
As the number of asthma and chronic obstructive pulmonary disease patients increases, multinational pharmaceutical companie...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
